 TDN MAGAZINE, The International Difference: Part III of A Painful Truth: "Welfare in Europe means to train the horse without any chemicals and make him race if he can face the challenge,” says France Galop's Dr. Roland Devolz. “In your country, welfare means to be allowed to use as many drugs as possible to ensure the horse will support training and race." Whose version is right? Part 3 of A Painful Truth examines North America's singular stance on medication. Download part three by clicking here.
(Click story headline once to expand, again to contract.) |
Owner Ken Ramsey and his wife Sarah have achieved new heights in the Thoroughbred racing world in 2013--no small feat, given all they've accomplished in the business already. In the first of a two-part series, the TDN's Christina Bossinakis talks to Ken Ramsey and farm manager Mark Partridge about the method to the madness. Jockey Eddie Ahern will not be eligible to race until 2023 after being stood down by the British Horseracing Authority for his involvement in a racing scandal, Jessica Martini chats with Joe Moss, who made more than a little splash this week in Timonium, and there's new Rising Star in town. Download today's TDN now!
|  | 1st at BEL | $75K Opt. Clm. ($77K) [1 1/16m (T)] | Winner: Maximova, f, 3 by Danehill Dancer (Ire) |
1st-BEL, $77,000, Alw, Opt. Clm. ($75,000), NW1X, 3yo, f, 1 1/16mT, 1:43 1/5, fm.MAXIMOVA, f, 3, Danehill Dancer (Ire)1st Dam: Honoria (Ire) (SW-Ire), by Sadler's Wells2nd Dam: Tedarshana (GB), by Darshaan (GB)3rd Dam: Te Kani, by Northern DancerMaximova was favored in her career debut over the yielding turf at the Big A Apr. 14, and duly rewarded her backers by coming home a one-length winner (click here for ‘In Sharper Focus’). Sent off a tasty 5-1 chance in this second go, she was caught flat-footed at the start, forcing her to spot the field a few lengths. However, jockey Jose Lezcano remained confident on the filly, allowing her to trail through pokey opening fractions of :24.48 and :49.51. Pulling her way into contention along the inner down the backstretch, she was shuffled back approaching the quarter pole, but responded quickly when finding a seam turning for home. Finding daylight along the rail in early stretch, the homebred cruised up to reach the leaders, angled out three wide to overtake Corporate Culture (English Channel) and the tiring pacesetter Lemon Song (Lemon Drop Kid) late and burst clear to hand Corporate Culture a 1 3/4-length defeat. Lemon Song faded to last. Click for the brisnet.com chart, or the free brisnet.com catalogue-style pedigree. VIDEO. Lifetime Record: 2-2-0-0, $85,200. O/B-Gallagher's Stud (NY). T-Christophe Clement. 
| Declan's Warrior Takes Belmont's Gygistar S.| 2nd at BEL | Gygistar S. ($85,000) [7f] | Winner: Declan's Warrior, c, 3 by Majestic Warrior |
GYGISTAR S., $83,300, BEL, 5-22, 3yo, 7f, 1:20 4/5, ft. 1-- DECLAN'S WARRIOR, 122, c, 3, by Majestic Warrior1st Dam: Comanche Star, by Saint Ballado2nd Dam: Deceit Princess, by Vice Regent3rd Dam: Deceit, by Prince JohnO/B-Lucky Shamrock Stable (KY); T-Nicholas Zito; J-Jose Lezcano. $51,000. Lifetime Record: GSW, 5-4-1-0, $268,770. *1/2 to Canonize (Aldebaran), SW & MGSP, $271,484. 2-- Tenango, 118, g, 3, Lion Heart--Ochi Chernye, by Mr. Greeley. ($40,000 2yo ‘12 BESMAY; $10,000 RNA yrl '11 COLAUG). O-Lawrence Roman. $17,000. 3-- Battier, 122, c, 3, Tale of the Cat--Whobabydatiz, by Boston Harbor. ($13,000 2yo ‘12 FTMMAY). O-Eclipse Thoroughbred Partners and Brahman Red LLC. $8,500. Margins: NK, 1, 2 1/4. Odds: 0.50, 6.90, 3.10. Declan's Warrior, sent off the 1-2 favorite, settled behind the pacesetting Happy My Way (Wilko) who reeled off early opening splits of :22.52 and :45.13. Seemingly beaten turning for home, the GIII Bay Shore S. winner found another gear in the stretch and wore down the new leader Tenango in the late stages to win by a half-length. Battier, who broke slow and spotted the field a couple of lengths, closed along the rail to be third.
|
(Click story headline once to expand, again to contract.) |
In Today's TDN: Day 2 F-T Midlantic Topper © Lydia Williams The final day of the Fasig-Tipton Midlantic sale in Timonium closes out in style with a $450,000-session topping colt by Malibu Moon...Group 1 winner Olympic Glory to miss Saturday's G1 Irish 2000 Guineas...NY State Gaming Commission and NYRA announced enhanced security protocol for Belmont S...Bill Oppenheim compares last weekend's GI Preakness to past U.S. Classics and delves into this season's leading sires.. All that and more in Wednesday's TDN.
| Malibu Moon Colt Brings $450K at TimoniumFTMJUL
hip 396 | 2-year-old C | Malibu Moon--Partyship | $450,000 | | Breeder: Matthew Herbener (Ky) | | Buyer: Gary Contessa, Wounded Warrior Stable | | Consignor: Eddie Woods, Agent XXI |
Trainer Gary Contessa, active during both sessions of the Midlantic sale, made his biggest splash Tuesday when going to $450,000 for a son of Malibu Moon out of Partyship (Premiership). Contessa was bidding on behalf of Chip McEwan's Wounded Warrior Stable. The juvenile is a half-brother to graded stakes placed Barrier Reef (Mizzen Mast). 
|
The latest forum post by Byron Rogers from
yesterday
at 5:03 PM:
New Study on EIPH confirms Salix is performance Enhancing
A new study by Dr Joe Pagan and colleagues that is to be presented at the upcoming Equine Symposium in New Mexico shows that Salix enhances performance independent of alleviating EIPH. The summary of the findings were that Salix (also known as Lasix and Furosemide), essentially acts as a lactate buffer (which is why the TCO2 levels for testing are higher on horses that use lasix than those that do more...
(Click here to visit the entire TDN Forum)
|
Sign Up for Alerts!
Learn More or Subscribe for FREE! Click Here
![Click here to download Today's Edition [3.59Mb - PDF]](/graphics/member_menu_todaysedition3.gif)
![Click HERE to view today's edition in your browser [3.59Mb - PDF]](/graphics/member_menu_today_view2.gif){kind=small}
![Click HERE to save today's edition to your computer [3.59Mb - PDF]](/graphics/member_menu_today_save2.gif){kind=small}
For the best site experience, the latest version of Adobe Acrobat Reader is suggested. Click here to get it free.
